Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials Chris H. TakimotoAhmad Awada Review 17 November 2007 Pages: 535 - 548
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma Gavin J. GordonMadhubalan ManiRaphael Bueno Original Article 24 May 2007 Pages: 549 - 558
Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells Toru YoshidaTakashi KondoKazuhiro Tsukada Original Article 16 May 2007 Pages: 559 - 567
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer J. LeeY. H. ImJ. H. Yang Original Article 17 May 2007 Pages: 569 - 577
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer A. R. ClampP. Schöffskion behalf of the EORTC New Drug Development Group Original Article 23 May 2007 Pages: 579 - 585
Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer Kenji OkumuraEiji MekataTohru Tani Original Article 23 May 2007 Pages: 587 - 594
Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats Masaharu OnoueAkinobu KuritaTeruo Yokokura Original Article 05 June 2007 Pages: 595 - 605
Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys Lu XuChristina L. ZuchBert L. Lum Original Article 05 June 2007 Pages: 607 - 614
A late phase II study of S-1 for metastatic pancreatic cancer Takuji OkusakaAkihiro FunakoshiHiroshi Saito Original Article 23 May 2007 Pages: 615 - 621
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer Yeon Hee ParkJae-Lyun LeeYoon-Koo Kang Original Article 24 May 2007 Pages: 623 - 629
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy Jae-Lyun LeeMin-Hee RyuYoon-Koo Kang Original Article 23 May 2007 Pages: 631 - 637
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells Deguang MuWei ZhangFaguang Jin Original Article 04 July 2007 Pages: 639 - 645
Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates Stacie L. StapletonPatrick A. ThompsonSusan M. Blaney Original Article 31 May 2007 Pages: 647 - 652
A combination of IFN-β and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation Atsushi NatsumeToshihiko WakabayashiJun Yoshida Original Article 13 June 2007 Pages: 653 - 659
Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors Kimberly A. VarkerJacqueline CampbellManisha H. Shah Original Article 23 June 2007 Pages: 661 - 668
Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo Jörg SchwockNhu-An PhamDavid W. Hedley Original Article 20 June 2007 Pages: 669 - 681
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization Tsutomu TanakaMasafumi IkedaSatoru Iwasa Original Article 31 May 2007 Pages: 683 - 688
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma Walter M. StadlerApurva A. DesaiFrank M. Torti Original Article 14 June 2007 Pages: 689 - 694
An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin Alberto GabizonRut IsacsonRama Sapir Original Article 05 June 2007 Pages: 695 - 702
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines Hellinida ThomadakiChris Milto TsiapalisAndreas Scorilas Original Article 13 June 2007 Pages: 703 - 711
PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment Ernesto VignaEugenio LuciaFortunato Morabito Short Communication 05 June 2007 Pages: 713 - 716
A case of mixed adult Wilms’ tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO) Thomas YauC. H. LeongR. J. Epstein Short Communication 15 June 2007 Pages: 717 - 720